Sector valuations Perspective Therapeutics, Inc.
Stocks
CATX
US46489V3024
Biotechnology & Medical Research
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.975 USD | +0.85% |
|
-2.16% | +7.09% |
| Jul. 08 | Perspective Therapeutics, Inc. Announces Executive Changes | CI |
| Jul. 08 | Perspective Therapeutics Names Paul Lyne Chief Science Officer as Co-Founder Michael Schultz Moves to Advisory Role | MT |
Main competitors
| P/E (N) | Price to Book (N) | PEG (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | -2.67x | 1.31x | 0.13x | 352.85x | -1.18x | -1.19x | -.--% | 336M | |
| 34.73x | 4.41x | 1.54x | 6.08x | 18.79x | 26.09x | 0.95% | 49.7B | |
| -22.46x | 17.53x | -0.66x | 337.12x | -20.58x | -20.48x | -.--% | 38.09B | |
| 47.81x | 7.11x | 0.29x | 4.82x | 30.92x | 35.77x | -.--% | 35.29B | |
| 25.61x | 4.86x | 5.32x | 2.82x | 12.2x | 18.59x | -.--% | 35.13B | |
| 27.15x | 2.22x | 0.59x | 7.96x | 19.98x | 23.44x | 0.42% | 27.22B | |
| 31.76x | 15.8x | 2.93x | 5.12x | 23.31x | 24.44x | -.--% | 15.36B | |
| 24.14x | 2.53x | 0.83x | 2.05x | 9.02x | 14.26x | 1.11% | 13.89B | |
| 24.03x | 1.34x | 0.17x | 1.91x | 11.58x | 13.16x | -.--% | 13.02B | |
| -32.64x | 9.9x | 1.34x | 124.7x | -35.5x | -61.77x | -.--% | 11.76B | |
| 61.61x | 5.15x | 0.4x | 9.2x | 26.13x | 28.57x | 0.45% | 11.18B | |
| 37.38x | 3.35x | -0.12x | 3.34x | 12.98x | 15.84x | -.--% | 11.04B | |
| -27.12x | 23.71x | -0.68x | 6.44x | 157.44x | -521.64x | -.--% | 9.62B | |
| -31.07x | 8.99x | -13.64x | 997.65x | -26.45x | -25.91x | -.--% | 10.05B | |
| 34.49x | 3.99x | 1.8x | 4.25x | 17.89x | 27.73x | 0.63% | 9.56B | |
| -32.36x | 8.33x | 7.14x | 95.16x | -21.35x | -20.59x | -.--% | 9.38B | |
| -15.12x | 218.88x | -0.29x | 9.87x | -14.61x | -13.86x | -.--% | 9.03B | |
| -20.3x | 7.67x | -1.6x | 2817.61x | -17.06x | -16.64x | -.--% | 8.59B | |
| 33.72x | - | -0.12x | 15.52x | 27.7x | 30x | -.--% | 8.49B | |
| Average | 10.46x | 19.28x | 0.28x | 252.87x | 12.17x | -22.33x | 0.19% | 17.2B | |
| Weighted average by Cap. | 16.76x | 13.68x | 0.81x | 155.89x | 12.37x | -5.02x | 0.26% |
- Stock Market
- Stocks
- CATX Stock
- Sector Perspective Therapeutics, Inc.
- Sector valuations
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
